Manufacturing of finished dosage forms
Driving efficiency is our key
From small batch to high volume production: Get reliable & flexible supply at the best price!
As fully integrated pharmaceutical company, we offer our clients a competitive supply chain management. We drive efficiency by keeping our supply chains simple and reaching economies of scales in our own manufacturing sites. Modern supply chain solutions and a lean management approach ensure that our products reach the right place in the right condition and quantity at the best price on time. Our two own manufacturing sites in Cyprus and India as well as our global network of contract manufacturers allow us to manufacture nearly any kind of formulation and dosage form. No matter if a controlled drug or a special dosage form (like patches or inhalers) – our about 60 years experience and our excellent know how in terms of regulatory and quality requirements guarantee the best possible supply chain for you. Both sites are currently enlarging their production capacities, equipment, and warehouse storage to drive efficiency and to meet the growing demand of our customers. With our new high potent manufacturing block in India we are committed to drive for growth and innovation and are now able to manufacture a well-defined and specialized portfolio of highly potent drug formulations inhouse.
All our pharmaceutical production plants are equipped with most up-to-date technologies, highly qualified professionals and highest safety standards. This ensures full compliance with Good Manufacturing Practice (GMP). Apart from the most important governmental approvals, our sites are periodically inspected by leading pharmaceutical companies.
Tiefenbacher manufacturing at a glance
Your benefits of our own production facilities
Our manufacturing operations for better healthcare – by manufacturing high-quality pharmaceuticals with added value for patients worldwide. We stand for reliability, the highest standards of safety and quality, and a forward-looking approach along the entire pharmaceutical value chain.
efficiency driven supply chain management
own state-of-the-art production sites
small batch and high volume production
SPC waiver site in EU (Cyprus)
efficiency driven supply chain management
own state-of-the-art production sites
small batch and high volume production
SPC waiver site (DELORBIS)
up to 3 bn units p.y.
production capacity
GMP compliance
FDA approval
(TIEFENBACHER LABORATORIES)
regulatory and quality excellence
up to 3 bn units p.y.
production capacity
GMP compliance
FDA approval
(AET Labs)
regulatory and quality excellence
European manufacturing site of TIEFENBACHER GROUP
High volume productions made in Europe
The manufacturing facilities of TIEFENBACHER GROUP on Cyprus have been designed to accommodate the bulk production and primary and secondary packaging operations of non-sterile oral solid dosage forms (tablets, capsules, and powder suspensions for reconstitution). The production and packaging lines are equipped with sophisticated technology from the first manufacturing step throughout to the last packaging step and are flexible to manage small batch as well as high volume productions. Thanks to our highly competent personnel as well as the state-of-the-art equipment available in the quality control laboratory we can also offer to our partners:
- EU batch testing and release of pharmaceutical products
- ICH stability studies at long-term, intermediate, and accelerated conditions for all zones (incl. zone IVb)
- many analytical laboratory services (e. g. chemical testing of raw materials and drug products, method validation/transfer, comparative dissolution profiles) and support from our experienced analysts
- technology transfer
- import/storage/warehousing
Indian manufacturing site of TIEFENBACHER GROUP
Our advanced, FDA approved manufacturing site in India
With TIEFENBACHER LABORATORIES, we own a second state-of-the-art manufacturing site, located in Hyderabad, India. Featuring a GMP compliant environment on a 32.000 m² sized plant, TIEFENBACHER LABORATORIES is equipped with the most modern technologies for manufacturing, testing, packing, warehousing, and releasing solid oral dosage forms. With our new high potent manufacturing block we are committed to drive for growth and innovation and are now able to produce a well-defined and specialized portfolio of highly potent drugs.
Quality control is an integral part of TIEFENBACHER LABORATORIES´ manufacturing process. The facility holds the ISO 14001:2014 and ISO 18001:2015 certifications and was successfully inspected by the German BGV, the US FDA authorities, the Russian MIT, and the Turkish Ministry of Health.